Natalia Aptsiauri, Anahid Jewett, Arthur A Hurwitz, Michael R Shurin, Viktor Umansky
{"title":"重新定义癌症免疫疗法--优化、个性化和新的预测性生物标记物:第四届癌症免疫疗法和免疫监测(CITIM)会议,2015年4月27-30日,斯洛文尼亚卢布尔雅那。","authors":"Natalia Aptsiauri, Anahid Jewett, Arthur A Hurwitz, Michael R Shurin, Viktor Umansky","doi":"10.1007/s00262-016-1795-8","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":49658,"journal":{"name":"Progress of Theoretical Physics","volume":"109 1","pages":"875-83"},"PeriodicalIF":0.0000,"publicationDate":"2016-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11029488/pdf/","citationCount":"0","resultStr":"{\"title\":\"Redefining cancer immunotherapy-optimization, personalization, and new predictive biomarkers: 4th Cancer Immunotherapy and Immunomonitoring (CITIM) meeting, April 27-30, 2015, Ljubljana, Slovenia.\",\"authors\":\"Natalia Aptsiauri, Anahid Jewett, Arthur A Hurwitz, Michael R Shurin, Viktor Umansky\",\"doi\":\"10.1007/s00262-016-1795-8\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":49658,\"journal\":{\"name\":\"Progress of Theoretical Physics\",\"volume\":\"109 1\",\"pages\":\"875-83\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2016-07-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11029488/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Progress of Theoretical Physics\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1007/s00262-016-1795-8\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2016/1/25 0:00:00\",\"PubModel\":\"Epub\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Progress of Theoretical Physics","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1007/s00262-016-1795-8","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2016/1/25 0:00:00","PubModel":"Epub","JCR":"","JCRName":"","Score":null,"Total":0}
Redefining cancer immunotherapy-optimization, personalization, and new predictive biomarkers: 4th Cancer Immunotherapy and Immunomonitoring (CITIM) meeting, April 27-30, 2015, Ljubljana, Slovenia.